Assesses the introduction of the AQBioSim division of Sandbox AQ in June 2023. The new division focuses on using quantum-inspired techniques to enhance and optimize the drug discovery process.
SandboxAQ introduces AQBioSim division for drug discovery
The Analyst Team
Sam Lucero
Chief Analyst, Quantum Computing
Sam Lucero leads Omdia’s quantum computing research program. Omdia has produced standalone quantum computing research content since 2018. Sam consolidates and extends this work into a full subscription research program, alongside Omdia’s quantum computing B2B media and events businesses.
Sam is a seasoned technology industry analyst with over 20 years’ experience helping clients assess market opportunities and optimize their competitive strategy. In offering expert opinion, Sam has been widely quoted in the media, including The Economist, the Financial Times, The New York Times, and The Wall Street Journal. Sam joined Omdia via its 2019 acquisition of IHS Markit Technology. He started his analyst career in 2001 at InStat, covering the semiconductor and networking equipment markets. After graduating from the University of California, San Diego, Sam spent three years working in Japan before returning to the US to earn an MBA (Hons.) from Thunderbird School of Global Management.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Omdia Recommends
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Thank you
Our expert analysts will review your question and the Ask an Analyst team will get back to you. We aim to respond within 24 hours, but we’re often quicker.
Ask an Analyst
Our team of experts are here to answer your questions. From advice on market trends to a query on research point, and everything in between, we want to hear from you.
Ask an analyst is available as part of a subscription. If you'd like access, contact us today.